Exploring Recent Advancements in Migraine Treatment: Insights from Clinical Neurology

Dear Colleagues,

The treatment landscape for migraine has witnessed significant advancements in recent years. Migraine, a complex, prevalent, and highly disabling neurological disorder, is often underdiagnosed and undertreated. In recent years, there have been important advances in the pathophysiology of the disease that have facilitated the development of new drugs for both the symptomatic and preventive treatments. These novel therapies not only expand the range of available treatments but also offer substantial advantages due to their specificity for migraine treatment, increased effectiveness, and improved tolerability.

Presently, clinicians have a more extensive therapeutic arsenal for managing migraine and must carefully select the optimal treatment for each patient from the diverse options available. This thematic Special Issue aims to explore the challenges contributing to the undertreatment of migraine, emphasizing recent therapeutic breakthroughs and underscoring the importance of initiating symptomatic and preventive treatment in the early phases. By providing a practical perspective, it enables clinicians to familiarize themselves with innovative treatments and gain insights into the underlying pathophysiological foundations of therapies currently in development.

Dr. Pablo Irimia
Dr. Dimos-Dimitrios Mitsikostas
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• migraine
• chronic migraine
• treatment
• progression
• stigma